PAVM PAVmed Inc.
Healthcare$6.14-3.91%ClosedMarket Cap: $3.3M
As of 2026-05-26
Valuation
P/E (TTM)
12.74
PEG
—
P/B
0.00
P/S
0.16
EV/EBITDA
-0.00
DCF Value
$-19.01
FCF Yield
-76454.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
-340.6%
Operating Margin
-36492.6%
Net Margin
-31757.1%
ROE
-18676.7%
ROA
-15426.5%
ROIC
-19014.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $22.0M | -340.9% | $-8.04B | $-6.99B | $— | — |
| Q4 null | $52.0K | -98.1% | $-6.8M | $-1.3M | $— | — |
| FY null | $71.0K | -354.9% | $-21.8M | $401.0K | $— | — |
| Q3 null | $5.0K | -1000.0% | $-4.8M | $-5.4M | $— | — |
| Q2 null | $6.0K | -583.3% | $-4.7M | $-11.9M | $— | — |
| Q1 null | $8.0K | -887.5% | $-5.4M | $19.0M | $— | — |
| Q4 null | $10.0K | -380.0% | $-5.2M | $1.4M | $— | — |
| FY null | $3.0M | -101.6% | $-44.5M | $39.8M | $— | — |
| Q3 null | $996.0K | -38.7% | $-11.6M | $64.4M | $— | — |
| Q2 null | $979.0K | -101.3% | $-13.7M | $-10.8M | $— | — |
| Q1 null | $1.0M | -72.7% | $-14.0M | $-15.2M | $— | — |
| Q4 2023 | $1.0M | -53.6% | $-16.4M | $-14.0M | $-58.07 | — |